Pepdox
Studies
Peptides
Calculator
Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks. | Pepdox
Home
/
Search
/
PMID 39217571
Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks.
Journal of the American College of Cardiology
2024
PMID: 39217571
View on PubMed
DOI: 10.1016/j.jacc.2024.08.035
Semaglutide
Authors
Faust, Jeremy Samuel
Keywords
COVID-19
clinical trials
semaglutide